MIRA shareholders elect five directors and ratify auditor at 2026 annual meeting

MIRA PHARMACEUTICALS, INC.

At Sept 11, 2026 annual meeting, 26,499,076 shares voted (63.06% quorum); five directors elected.
Erez Aminov, Matthew Whalen, Matthew Del Giudice, Denil Shekhat, Edward MacPherson elected with ~20.1-20.6M votes each.
Ratification of Salberg & Company as auditor for FY2026 passed: 25,950,852 for, 158,064 against, 390,160 abstain.
Adjournment proposal approved: 24,897,741 for, 1,205,307 against, 396,028 abstain.
Record date was July 21, 2026; 42,022,087 shares outstanding.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.